Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Magn Reson Med. 2011 Oct 17;67(3):801–807. doi: 10.1002/mrm.23065

Figure 3.

Figure 3

(A) Immunostaining of hypoxia marker pimonidazole of representative tumors of control mice and pyruvate-treated mice (1 h and 5 h after [1-13C]pyruvate injection). (B) Pimonidazole positive area in control tumors (n = 5) and tumors 1 h after (n=5) and 5 h after (n=5) [1-13C]pyruvate injection.